Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Coccidia-specific phosphate transporter (TgPT2)** is a membrane transporter found in *Toxoplasma gondii* and other coccidian parasites, localized to the plasma membrane and essential for parasite survival and growth[1]. TgPT2 mediates the uptake of inorganic phosphate (Pi) from the environment, which is critical for ATP production and overall parasite energy metabolism. Although ATP and AMP can competitively inhibit phosphate uptake, direct ATP import is not mediated by TgPT2, suggesting the existence of additional, as-yet-uncharacterized transport mechanisms[1][5]. TgPT2 is restricted to coccidia and not present in other apicomplexans, making it an attractive target for selective anti-coccidial drug design[1]. Disruption of TgPT2 leads to growth arrest, reduced motility, and impaired invasion, confirming its critical role in parasite pathogenicity[1]. While no direct drugs or biomarkers have been described against this transporter, its essentiality and specificity indicate strong potential as a novel therapeutic target in treating coccidiosis and toxoplasmosis. **Key clarification:** The term "Coccidia ATP transport" is not specific enough for structured biochemical taxonomy; for detailed molecular targeting, refer to the actual characterized transporters such as TgPT2. If you meant ATP synthase, mitochondrial carrier proteins, or general phosphate uptake machinery, these should be named explicitly for data standardization[1][4][5].
Transport inhibition (disrupting phosphate or nucleotide uptake, potentially causing parasite energy deficit and death)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coccidia-specific phosphate transporter (TgPT2) (TgPT2).